| CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers (NCT05122221) | Corregene Biotechnology Co., Ltd | 2022-07-17 |
| Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa (NCT05414097) | UNC Lineberger Comprehensive Cancer Center | 2022-07-16 |
| Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer (NCT05475847) | Fudan University | 2022-07-01 |
| A Family-based Intervention to Improve Pap Test Screening Among Under-screened Chinese American Immigrant Women (NCT03961412) | University of Nevada, Reno | 2022-07-01 |
| Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 (NCT05383482) | Laekna Limited | 2022-07-01 |
| Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal (NCT05489978) | Kathmandu University School of Medical Sciences | 2022-06-15 |
| Gynaecology Exercise and Mindfulness Study (NCT05561413) | University of Ulster | 2022-06-14 |
| Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy (NCT04989647) | The Central and Eastern European Gynecologic Oncology Group | 2022-06-10 |
| Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring (NCT05774561) | The Institute of Molecular and Translational Medicine, Czech Republic | 2022-06-01 |
| Interventions to Decrease Financial Toxicity (NCT05939440) | University of Alabama at Birmingham | 2022-06-01 |
| Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal Ablation (NCT05472311) | University of Washington | 2022-05-17 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine (NCT05340322) | Duke University | 2022-05-01 |
| Telecytology as a Triage Tool in LMICs (NCT05474404) | University Hospital, Geneva | 2022-04-25 |
| SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study) (NCT05133661) | Jhpiego | 2022-04-19 |
| Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies (NCT05342506) | Peking Union Medical College Hospital | 2022-04-18 |
| Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients (NCT05401175) | Chongqing University Cancer Hospital | 2022-04-13 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer (NCT04831580) | GOG Foundation | 2022-03-22 |
| Connecting Audio and Radio Sensing Systems to Improve Care at Home (NCT05344950) | UNC Lineberger Comprehensive Cancer Center | 2022-03-21 |
| Cervical Cancer Screening Strategies (NCT05309122) | Lei Li | 2022-03-19 |
| Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients (NCT05277688) | Ruijin Hospital | 2022-03-15 |
| Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial (NCT05367206) | Sun Yat-sen University | 2022-03-14 |
| DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening (NCT05290428) | Peking Union Medical College Hospital | 2022-03-12 |
| The Organ Transplant Recipient HPV and Skin Cancer Study (NCT05284877) | Merete Haedersdal | 2022-03-10 |
| A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors (NCT05238883) | HiFiBiO Therapeutics | 2022-03-10 |
| Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO (NCT05078047) | UNICANCER | 2022-03-08 |
| ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab (NCT05082259) | Institute of Cancer Research, United Kingdom | 2022-03-02 |
| AK105 Combined With Anlotinib in Patients With Cervical Cancer (NCT05137171) | The First Affiliated Hospital of Zhengzhou University | 2022-03-01 |
| Spectroscopy and Artificial Intelligence to Disrupt the Status Quo in Cervical Cancer Screening (NCT05236855) | IWK Health Centre | 2022-03-01 |
| Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix (NCT05063916) | M.D. Anderson Cancer Center | 2022-02-28 |
| A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer (NCT05179239) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-02-26 |
| Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer (NCT05255393) | Memorial Sloan Kettering Cancer Center | 2022-02-15 |
| Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer (NCT05021237) | University of Texas Southwestern Medical Center | 2022-02-01 |
| Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial (NCT04312178) | Centre Hospitalier Universitaire Dijon | 2022-01-05 |
| Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women (NCT05570331) | Ding Ma | 2022-01-01 |
| Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer (NCT05863377) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-01-01 |
| A Study of DeTIL-0255 in Adults With Advanced Malignancies (NCT05107739) | Nurix Therapeutics, Inc. | 2021-12-22 |
| A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer (NCT05557565) | Qilu Pharmaceutical Co., Ltd. | 2021-12-21 |
| A Study of Carilizumab Combined With Concurrent Chemoradiotherapy (NCT05151549) | Hunan Cancer Hospital | 2021-12-01 |
| Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia (NCT05125380) | Lund University | 2021-12-01 |
| A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours (NCT05057013) | Cancer Research UK | 2021-11-10 |
| HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV (NCT05247853) | Montefiore Medical Center | 2021-11-03 |
| Milademetan in Advanced/Metastatic Solid Tumors (NCT05012397) | Rain Oncology Inc | 2021-11-01 |
| Strategies to Improve the Experience of Gynaecological Screening (NCT05131581) | Uppsala University | 2021-11-01 |
| Asian Multicenter Prospective Study of ctDNA Sequencing (NCT05099978) | National Cancer Center, Japan | 2021-11-01 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers (NCT04708470) | National Cancer Institute (NCI) | 2021-10-05 |
| A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer (NCT05033132) | Agenus Inc. | 2021-10-01 |
| A Study of NX-1607 in Adults With Advanced Malignancies (NCT05107674) | Nurix Therapeutics, Inc. | 2021-09-29 |
| Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy (NCT05120167) | Cirbia Silva Campos Teixeira | 2021-09-29 |
| Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2) (NCT04934982) | Hua Jiang | 2021-09-24 |
| Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR (NCT05047913) | M.D. Anderson Cancer Center | 2021-09-20 |
| An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old (NCT05056402) | Xiamen University | 2021-09-19 |
| A Proximity-incentive Strategy for Cervical Cancer Screening (NCT04716127) | University Hospital, Montpellier | 2021-09-16 |
| Clinical Evaluation of Detection of High Risk HPV in Urine (NCT05210348) | Peking University People's Hospital | 2021-09-15 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer (NCT04982237) | Akeso | 2021-08-27 |
| A Study of PRT1419 in Patients With Advanced Solid Tumors (NCT04837677) | Prelude Therapeutics | 2021-08-11 |
| Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer (NCT05051722) | Mayo Clinic | 2021-08-03 |
| GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors (NCT04977453) | GI Innovation, Inc. | 2021-08-02 |
| Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer (NCT04974346) | Zhejiang Cancer Hospital | 2021-08-02 |
| Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer (NCT04906993) | Jiangsu HengRui Medicine Co., Ltd. | 2021-07-23 |
| Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV (NCT04587050) | Imperial College London | 2021-07-19 |
| Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer (NCT07605507) | Siriraj Hospital | 2021-07-15 |
| Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer (NCT05564286) | Shantou University Medical College | 2021-07-01 |
| Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer (NCT05189028) | Chuangzhen Chen | 2021-07-01 |
| Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy (NCT04646005) | Regeneron Pharmaceuticals | 2021-06-28 |
| Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy (NCT04800978) | Samsung Medical Center | 2021-06-14 |
| Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NCT04913337) | NGM Biopharmaceuticals, Inc | 2021-06-09 |
| Study of XB002 in Subjects With Solid Tumors (JEWEL-101) (NCT04925284) | Exelixis | 2021-06-07 |
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-05-28 |
| A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors (NCT04895709) | Bristol-Myers Squibb | 2021-05-27 |
| Impact of Catch-up HPV Vaccination (NCT05462249) | University Hospital, Brest | 2021-05-21 |
| A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer (NCT04974827) | Hunan Cancer Hospital | 2021-05-20 |
| Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB3,IIA2) (NCT04939831) | Obstetrics & Gynecology Hospital of Fudan University | 2021-05-12 |
| RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma (NCT04762225) | Repertoire Immune Medicines | 2021-05-10 |
| Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB1,IB2,IIA1) (NCT04929769) | Obstetrics & Gynecology Hospital of Fudan University | 2021-05-07 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden (NCT04910802) | Miriam Elfström | 2021-05-03 |
| Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer (NCT04918628) | Taizhou Hospital | 2021-05-01 |
| Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. (NCT05610501) | Universitaire Ziekenhuizen KU Leuven | 2021-05-01 |
| Education, Immigration and HPV Vaccination: an Informational Randomized Trial (NCT04905030) | Karolinska Institutet | 2021-04-28 |
| Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama (NCT04093388) | University of Alabama at Birmingham | 2021-04-26 |
| Increase in Response by Offering Self-sampling Devices in Belgian GP Practices to Non-screened Women (NCT04903561) | Sciensano | 2021-04-19 |
| The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female (NCT05045755) | Jun Zhang | 2021-04-13 |
| RTX-321 Monotherapy in Patients With HPV 16+ Tumors (NCT04672980) | Rubius Therapeutics | 2021-04-08 |
| The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female (NCT04969445) | Jun Zhang | 2021-03-30 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors (NCT04272034) | Incyte Corporation | 2021-03-26 |
| Rice Technologies for Cervical Cancer Screening and Diagnosis (NCT05372484) | M.D. Anderson Cancer Center | 2021-03-24 |
| A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies (NCT04772989) | Arcus Biosciences, Inc. | 2021-03-19 |
| Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer (NCT04799639) | Sun Yat-sen University | 2021-03-18 |
| A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer (NCT04499521) | University of Virginia | 2021-03-17 |
| Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age (NCT04782895) | Xiamen University | 2021-03-14 |
| The LYSA (Linking You to Support and Advice) Trial (NCT05035173) | University College Cork | 2021-03-13 |
| A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma (NCT06226350) | Shandong New Time Pharmaceutical Co., LTD | 2021-03-04 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers (NCT04464967) | NKGen Biotech, Inc. | 2021-03-01 |
| Laparoscopic Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer (NCT07626996) | Zagazig University | 2021-03-01 |
| Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury (NCT04819685) | Peking Union Medical College Hospital | 2021-03-01 |